Highnoon Laboratories Initiates New Pharmaceutical Facility
Highnoon Laboratories Limited (PSX: HINOON) recently held a significant groundbreaking ceremony for Project FORCE. This greenfield manufacturing expansion project is strategically located at the Quaid-e-Azam Business Park in Sheikhupura. This major step forward signals the establishment of an advanced production site, aiming to boost Pakistan’s healthcare infrastructure.
Project FORCE: A Vision for Global Standards
The groundbreaking event occurred on January 22, 2026, within the Special Economic Zone. Project FORCE represents Highnoon’s commitment to establishing a world-class, highly efficient, and globally compliant new pharmaceutical manufacturing facility in Pakistan. Consequently, this initiative is poised to elevate the nation’s pharmaceutical production capabilities.
Furthermore, this state-of-the-art facility will significantly strengthen Highnoon’s manufacturing footprint. It aims to support future growth and enhance the company’s capacity to serve both domestic and international markets. The alignment with internationally recognized quality and regulatory standards ensures top-tier pharmaceutical output.
Investing in Excellence and Sustainable Growth
Highnoon emphasizes that this initiative perfectly reflects its strategic vision. The company actively invests in world-class infrastructure and operational excellence. Ultimately, these efforts contribute to sustainable growth, even within the increasingly competitive global pharmaceutical landscape.
Highnoon Laboratories primarily focuses on the manufacture, import, sale, and marketing of a diverse range of pharmaceutical and related consumer products. This expansion will undoubtedly bolster their market position and production capabilities.
